Connection

Ross Arena to Interleukin-1

Back to Details
This is a "connection" page, showing publications Ross Arena has written about Interleukin-1.
Ross Arena
Connection Strength
0.535
Interleukin-1
  1. Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study. Clin Cardiol. 2018 Aug; 41(8):1004-1008.
    View in: PubMed
    Score: 0.139
  2. Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials. J Cardiovasc Pharmacol. 2018 07; 72(1):68-70.
    View in: PubMed
    Score: 0.138
  3. Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial). Circ Heart Fail. 2017 Nov; 10(11).
    View in: PubMed
    Score: 0.131
  4. Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2). Clin Cardiol. 2017 Sep; 40(9):626-632.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.